Problem statement: Answer the multiple-choice question.
Question: Which drug has a 30.511% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1cc(NC(=O)CC2CCCC2)n(-c2nc3ccccc3[nH]2)n1
b. CC(=O)c1cccc(-n2nnnc2SCC(=O)Nc2cc(C)on2)c1
c. CCn1c(=O)cc(C(F)(F)F)[nH]c1=S
Answer: c. CCn1c(=O)cc(C(F)(F)F)[nH]c1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(=O)cc(C(F)(F)F)[nH]c1=S
CCn1c(=O)cc(C(F)(F)F)[nH]c1=S
3-ethyl-2-sulfanylidene-6-(trifluoromethyl)-1H-pyrimidin-4-one